Companies: 10,795·Total market cap: $144.5T
Moderna, Inc.

Moderna, Inc.

MRNANASDAQHealthcare● Active
$47.44
$-4.15(-8.04%)
Market Cap$18.8B
P/E Ratio
52W High$59.55
52W Low$22.28

Moderna, Inc.(MRNA)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · MRNA · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$1.94B$3.20B$6.85B$18.88B$17.74B
Cost of Revenue$0.87B$1.46B$4.69B$5.42B$2.62B
Gross Profit$1.08B$1.74B$2.15B$13.46B$15.12B
Gross Margin %(computed)55.35%54.24%31.47%71.31%85.24%
Operating Expenses
R&D Expenses$3.13B$4.54B$4.84B$3.29B$1.99B
G&A Expenses$0.00B$1.03B$1.34B$1.01B$0.00B
Total Operating Expenses$4.15B$5.68B$6.39B$4.04B$1.82B
Operating Income($3.07B)($3.94B)($4.24B)$9.42B$13.30B
Operating Margin %(computed)-158.13%-123.32%-61.90%49.91%74.97%
Interest Income$0.31B$0.42B$0.42B$0.20B$0.02B
Interest Expense$0.00B$0.02B$0.04B$0.03B$0.02B
Income Before Tax($2.77B)($3.61B)($3.94B)$9.57B$13.29B
Income Tax Expense$0.05B($0.05B)$0.77B$1.21B$1.08B
Net Income($2.82B)($3.56B)($4.71B)$8.36B$12.20B
Net Margin %(computed)-145.16%-111.32%-68.84%44.30%68.80%
Per Share & EBITDA
EPS (Basic)$-7.26$-9.27$-12.34$21.26$30.31
Wtd Avg Shares0.39B0.38B0.38B0.39B0.40B
EBITDA($2.55B)($3.39B)($3.28B)$9.77B$13.53B
EBITDA Margin %(computed)-131.33%-106.10%-47.94%51.75%76.27%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解Moderna, Inc.

关于Moderna, Inc.(MRNA)损益表

Moderna, Inc.(MRNA)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,MRNA实现营收$1.94B,毛利润$1.08B(毛利率55.35%),净利润($2.82B)(净利率-145.16%)。

常见问题

MRNA · 4 问

Moderna, Inc.(MRNA)2025财年营收为$1.94B,同比down39.2%。

MRNA revenueMRNA salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08